WeightWatchers CEO who oversaw diet company’s move into weight loss drugs abruptly leaves role
WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
Weight-Loss Drug Cases Push Clinical Definition Into Legal Arena
A series of state and federal lawsuits challenging coverage exclusions for obesity drugs and procedures are testing the ...
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
Weight loss drugs like Ozempic and Wegovy are tremendously popular and effective. Patients should also be careful in using them
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
Novo Nordisk CEO grilled for steep cost of Ozempic and other weight loss drugs
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...
The Washington Post6d
Weight-loss drugs are supposed to be forever. Until they run out.
Maez Waibel lost more than 30 pounds in nine months on the new weight-loss drugs, sparking a substantial improvement in health. But instead of feeling happy and relieved, Waibel’s days have been ...
Medical News Today4d
Weight-loss surgery may preserve kidney health more effectively than GLP-1 drugs
People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...
Kailera Therapeutics nets $400 million as weight-loss drug market heats up
Kailera Therapeutics, a new venture looking to secure a foothold in the booming market for anti-obesity therapies, launched on Tuesday with $400 million in funding from four investors. The startup ...